Wildcat Capital Management, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 28, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$174.4M2026 Q3
Positions5
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Wildcat Capital Management, LLC reported 5 positions worth $174.4M as of September 30, 2026 (13F filed October 28, 2026). Largest holding: ULCC (96.1%). Biggest move: new buy NETSKOPE INC ($1.1M).

5 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ULCCFrontier$167.5M96.07%28,061,351——+33.3%
▸ 2 ALLOAllogene Therapeutics$4.7M2.68%2,920,787——-47.6%
▸ 3NetskopeNetskope$1.1M0.65%65,174———
▸ 4 FIGRFigure Technology Solutions$845.3K0.48%29,299——-12.1%
▸ 5 PCORProcore Technologies$199.2K0.11%3,851——+49.9%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Wildcat Capital Management, LLC hold as of Q3 2026?

Wildcat Capital Management, LLC reported 5 positions worth $174.4M in its Q3 2026 13F filing. Largest positions: ULCC (96.1%), ALLO (2.7%), NETSKOPE INC (0.7%), FIGR (0.5%) and PCOR (0.1%).

What did Wildcat Capital Management, LLC buy in Q3 2026?

New positions: NETSKOPE INC, FIGR and PCOR.

What did Wildcat Capital Management, LLC sell in Q3 2026?

Sold out entirely: CHYM.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.